The estimated Net Worth of Krishnamurthy Balachandran is at least $161 Mille dollars as of 27 August 2012. Krishnamurthy Balachandran owns over 5,000 units of Neurometrix stock worth over $161,387 and over the last 14 years Krishnamurthy sold NURO stock worth over $0.
Krishnamurthy has made over 4 trades of the Neurometrix stock since 2012, according to the Form 4 filled with the SEC. Most recently Krishnamurthy bought 5,000 units of NURO stock worth $3,350 on 27 August 2012.
The largest trade Krishnamurthy's ever made was buying 5,000 units of Neurometrix stock on 27 August 2012 worth over $3,350. On average, Krishnamurthy trades about 1,429 units every 1 days since 2011. As of 27 August 2012 Krishnamurthy still owns at least 40,449 units of Neurometrix stock.
You can see the complete history of Krishnamurthy Balachandran stock trades at the bottom of the page.
Krishnamurthy's mailing address filed with the SEC is C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM, MA, 02451.
Over the last 20 years, insiders at Neurometrix have traded over $14,886,276 worth of Neurometrix stock and bought 3,074,896 units worth $6,396,868 . The most active insiders traders include James Edeerfield Capital Lp..., Capital Partners, Lp Topline e Capital Management, Llc Mc .... On average, Neurometrix executives and independent directors trade stock every 45 days with the average trade being worth of $133,905. The most recent stock trade was executed by Thomas T Higgins on 2 May 2024, trading 498 units of NURO stock currently worth $2,226.
neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort and has several pipeline programs. the company is located in waltham, massachusetts and was founded as a spinoff from the harvard-mit division of health sciences and technology in 1996. for more information, please visit neurometrix.com. neurometrix markets the following products: quell® wearable pain relief technology™ quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. it combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. quell launc
Neurometrix executives and other stock owners filed with the SEC include: